Heidelberg Pharma AG announced the appointment of Dr. Andr-s Strassz as Chief Medical Officer and Dr. Mathias Locher as Chief Development Officer. Dr. Strassz joined the company in April 2020 as Senior Medical Officer to build up the clinical development function. He has strong experience in clinical development, including in oncology. Dr. Strassz joined Heidelberg Pharma from Affimed, where he served as Medical Director. Previously, he held positions in clinical development at Sandoz and Amgen, among others. He holds both an MD and MBA from the University of P-cs, Hungary.